News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
219,420 Results
Type
Article (20891)
Company Profile (117)
Press Release (198403)
Multimedia
Podcasts (38)
Webinars (14)
Section
Business (66735)
Career Advice (831)
Deals (9396)
Drug Delivery (79)
Drug Development (22384)
Employer Resources (145)
FDA (3721)
Job Trends (6316)
News (102132)
Policy (7562)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1550)
Academic (2)
Accelerated approval (8)
Adcomms (17)
Allergies (30)
Alliances (18206)
ALS (55)
Alzheimer's disease (684)
Antibody-drug conjugate (ADC) (118)
Approvals (3832)
Artificial intelligence (259)
Autoimmune disease (49)
Automation (22)
Bankruptcy (55)
Best Places to Work (5114)
BIOSECURE Act (12)
Biosimilars (73)
Biotechnology (65)
Bladder cancer (55)
Brain cancer (19)
Breast cancer (211)
Cancer (1669)
Cardiovascular disease (152)
Career advice (750)
Career pathing (37)
CAR-T (103)
CDC (18)
Cell therapy (273)
Cervical cancer (10)
Clinical research (18326)
Collaboration (774)
Compensation (190)
Complete response letters (18)
COVID-19 (1030)
CRISPR (48)
C-suite (487)
Cystic fibrosis (54)
Data (2144)
Decentralized trials (1)
Denatured (23)
Depression (49)
Diabetes (139)
Diagnostics (2710)
Digital health (17)
Diversity (10)
Diversity, equity & inclusion (37)
Drug discovery (121)
Drug pricing (61)
Drug shortages (4)
Duchenne muscular dystrophy (80)
Earnings (17119)
Editorial (23)
Employer branding (23)
Employer resources (122)
Events (33434)
Executive appointments (569)
FDA (4682)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (6)
Funding (728)
Gene editing (87)
Generative AI (29)
Gene therapy (196)
GLP-1 (368)
Government (1463)
Guidances (135)
Healthcare (5211)
HIV (29)
Huntington's disease (22)
IgA nephropathy (23)
Immunology and inflammation (60)
Immuno-oncology (18)
Indications (34)
Infectious disease (1129)
Inflammatory bowel disease (79)
Inflation Reduction Act (8)
Influenza (40)
Intellectual property (70)
Interviews (118)
IPO (3889)
IRA (17)
Job creations (1346)
Job search strategy (638)
JPM (30)
Kidney cancer (2)
Labor market (81)
Layoffs (210)
Leadership (19)
Legal (1228)
Liver cancer (44)
Longevity (10)
Lung cancer (215)
Lymphoma (165)
Machine learning (19)
Management (43)
Manufacturing (320)
MASH (34)
Medical device (2831)
Medtech (2849)
Mergers & acquisitions (5928)
Metabolic disorders (376)
Multiple sclerosis (68)
NASH (9)
Neurodegenerative disease (119)
Neuropsychiatric disorders (22)
Neuroscience (1135)
Neurotech (1)
NextGen: Class of 2026 (2176)
Non-profit (1721)
Now hiring (64)
Obesity (199)
Opinion (133)
Ovarian cancer (44)
Pain (71)
Pancreatic cancer (58)
Parkinson's disease (90)
Partnered (21)
Patents (114)
Patient recruitment (125)
Peanut (15)
People (28568)
Pharmaceutical (25)
Pharmacy benefit managers (3)
Phase 1 (5609)
Phase 2 (7729)
Phase 3 (6996)
Pipeline (1674)
Policy (105)
Postmarket research (630)
Preclinical (2959)
Press Release (61)
Prostate cancer (67)
Psychedelics (28)
Radiopharmaceuticals (75)
Rare diseases (277)
Real estate (2584)
Recruiting (58)
Regulatory (6174)
Reports (40)
Research institute (1352)
Resumes & cover letters (108)
Rett syndrome (3)
RNA editing (10)
RSV (41)
Schizophrenia (56)
Series A (130)
Series B (90)
Service/supplier (7)
Sickle cell disease (38)
Special edition (10)
Spinal muscular atrophy (56)
Sponsored (17)
Startups (2054)
State (1)
Stomach cancer (7)
Supply chain (38)
Tariffs (16)
The Weekly (15)
Vaccines (349)
Venture capital (64)
Weight loss (113)
Women's health (36)
Worklife (18)
Date
Last 7 days (211)
Last 30 days (777)
Last 365 days (10246)
2026 (1041)
2025 (10413)
2024 (12312)
2023 (14002)
2022 (16768)
2021 (18782)
2020 (17257)
2019 (15706)
2018 (11491)
2017 (11067)
2016 (10868)
2015 (11743)
2014 (8543)
2013 (7281)
2012 (7681)
2011 (7890)
2010 (7303)
Location
Africa (336)
Alabama (35)
Alaska (4)
Arizona (92)
Arkansas (4)
Asia (12684)
Australia (2304)
California (3435)
Canada (1098)
China (333)
Colorado (167)
Connecticut (107)
Delaware (178)
Europe (32198)
Florida (515)
Georgia (94)
Hawaii (3)
Idaho (12)
Illinois (242)
India (35)
Indiana (267)
Iowa (12)
Japan (173)
Kansas (43)
Kentucky (12)
Louisiana (8)
Maine (7)
Maryland (357)
Massachusetts (2955)
Michigan (129)
Minnesota (172)
Mississippi (5)
Missouri (47)
Montana (5)
Nebraska (11)
Nevada (23)
New Hampshire (16)
New Jersey (1105)
New Mexico (16)
New York (1214)
North Carolina (543)
North Dakota (9)
Northern California (1765)
Ohio (110)
Oklahoma (9)
Oregon (20)
Pennsylvania (606)
Puerto Rico (7)
Rhode Island (17)
South America (400)
South Carolina (8)
Southern California (1197)
Tennessee (61)
Texas (593)
United States (13236)
Utah (73)
Vermont (1)
Virginia (83)
Washington D.C. (32)
Washington State (279)
West Virginia (1)
Wisconsin (75)
Wyoming (1)
219,420 Results for "mela sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tisento Therapeutics Completes Enrollment in PRIZM, a Global Phase 2b Study of Zagociguat for the Treatment of MELAS
January 8, 2026
·
4 min read
Press Releases
Tisento Therapeutics Announces Publication of MELAS Interview Study, Incorporating Patients’ Perspectives to Elucidate Symptoms and Impacts of Rare Mitochondrial Disease
November 4, 2025
·
5 min read
Press Releases
First PRIZM Study Participant Enrolled in Tisento Therapeutics’ Open-Label Extension Study in MELAS
August 20, 2025
·
4 min read
Press Releases
Tisento Therapeutics Receives U.S. FDA Fast Track Designation for Zagociguat for the Treatment of MELAS
June 17, 2025
·
4 min read
Press Releases
Melas Syndrome Market Size to Reach USD 494.2 Million by 2035, Impelled by Increasing Prevalence of Genetic Mutations
February 5, 2025
·
10 min read
Press Releases
First Participant Dosed in Tisento Therapeutics’ Global Phase 2b PRIZM Study Evaluating Zagociguat for the Treatment of MELAS
January 27, 2025
·
4 min read
gene therapy
Advanced Therapies Week 2026: ‘Solving for Science’ and Weathering Global Complexity
Phacilitate’s annual event dawns as cell and gene therapies reach a new tipping point: the science has hit new heights just as regulatory and government policies spark momentum and frustration.
January 28, 2026
·
4 min read
·
Heather McKenzie
Job Trends
BioSpace
Reveals Fresh Design With 2026 Hotbed Maps, Highlighting Life Sciences Hubs
BioSpace
has revealed its new 2026 Hotbed Maps, showcasing seven regional life sciences hot spots.
January 20, 2026
·
2 min read
·
Chantal Dresner
Job Trends
Report: U.S. Life Sciences Job Market Report Q4 2025
BioSpace’s 2025 Q4 U.S. Life Sciences Job Market update highlights early signs of stabilization in biopharma hiring, with modest gains in job postings, slowing layoffs, and cautiously improving sentiment heading into 2026.
January 19, 2026
·
1 min read
·
BioSpace Insights
Genetown
Tisento Therapeutics Initiates Interview Study with Individuals with MELAS to Elucidate the Symptoms and Impact of Disease and Inform the Zagociguat Clinical Development Program
Tisento Therapeutics today announced the initiation of a patient interview study to identify and describe the signs, symptoms, and health-related quality-of-life impacts of MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes) that are most burdensome to adults and adolescents living with this rare mitochondrial disease.
October 25, 2023
·
4 min read
1 of 21,942
Next
